image credit: Tim Reckmann / Flickr

Pfizer-BioNTech Has Requested Full Approval of Their COVID-19 Vaccine From the FDA

May 7, 2021


Pfizer-BioNTech announced on May 7 that they have requested that the U.S. Food and Drug Administration (FDA) start the process of fully approving their COVID-19 vaccine. The companies will continue to supply the agency with additional data on vaccination safety and effectiveness on a rolling basis over coming weeks. The FDA issued an emergency use authorization for the shot in December, based on short-term data on safety and efficacy.

Read More on Time Health